Ionis Pharmaceuticals (IONS) Stock Looks Fully Priced On Its 67% Slide

Simply Wall St.11-22 00:09

Ionis Pharmaceuticals has seen its share price slide sharply in 2026, which puts fresh attention on whether the current valuation is still in line with what its sales can support. With sentiment now ...

Source Link
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment